Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Phase 2
Completed
- Conditions
- Bursitis
- Interventions
- Drug: EXPERIMENTALDrug: PLACEBO
- Registration Number
- NCT01205477
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Brief Summary
To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
- Clinical diagnosis of anserine bursitis
Exclusion Criteria
- Intraarticular pathology that reflects pain in the medial part of the knee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Methylprednisolone EXPERIMENTAL Infiltration of 40 mg of methylprednisolone acetate plus 1 mL of xylocaine Placebo PLACEBO Infiltration of 1 mL of xylocaine
- Primary Outcome Measures
Name Time Method WOMAC score 4 weeks The WOMAC (Westren Ontario and McMaster Universities) index is used to assess patients with osteoarthritis of the hip or knee using 24 parameters. It can be used to monitor the course of the disease or to determine the effectiveness of anti-rheumatic medications.
Pain, Stiffness and Physical functionVisual analogue scale (VAS) may be used ranging from 0 to 10.
- Secondary Outcome Measures
Name Time Method VAS satisfaction 4 weeks Visual Analoge Scale for satisfaction
Improvement 4 weeks Percentage of improvement
SAFETY 4 weeks Pain at infiltration site, ecchymosis, bleeding, paresthesias, skin infection, anaphilaxy, vasovagal reaction
Trial Locations
- Locations (1)
Hospital Universitario "José Eleuterio González"
🇲🇽Monterrey, Nuevo León, Mexico